Literature DB >> 28019011

Prognostic value of biochemical variables for survival after surgery for metastatic bone disease of the extremities.

Michala Skovlund Sørensen1, Thea Bechman Hovgaard1, Klaus Hindsø2, Michael Mørk Petersen1.   

Abstract

BACKGROUND AND
OBJECTIVE: Prediction of survival in patients having surgery for metastatic bone disease in the extremities (MBDex) has been of interest in more than two decades. Hitherto no consensus on the value of biochemical variables has been achieved. Our purpose was (1) to investigate if standard biochemical variables have independent prognostic value for survival after surgery for MBDex and (2) to identify optimal prognostic cut off values for survival of biochemical variables.
METHODS: In a consecutive cohort of 270 patients having surgery for MBDex, we measured preoperative biochemical variables: hemoglobin, alkaline phosphatase, C-reactive protein and absolute, neutrophil and lymphocyte count. ROC curve analyses were performed to identify optimal cut off levels. Independent prognostic factors for variables were addressed with multiple Cox regression analyses.
RESULTS: Optimal cut off levels were identified as: hemoglobin 7.45 mmol/L, absolute lymphocyte count 8.5 × 109 /L, neutrophil 5.68 × 109 /L, lymphocyte 1.37 × 109 /L, C-reactive protein 22.5 mg/L, and alkaline phosphatase 129 U/L. Regression analyses found alkaline phosphatase (HR 2.49) and neutrophil count (HR 2.49) to be independent prognostic factors.
CONCLUSIONS: We found neutrophil count and alkaline phosphatase to be independent prognostic variables in predicting survival in patients after surgery for MBDex.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  biochemical variables; joint replacement surgery; metastatic bone disease; orthopedic oncology; prognostication; survival

Mesh:

Substances:

Year:  2016        PMID: 28019011     DOI: 10.1002/jso.24537

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Prediction of survival after surgical management of femoral metastatic bone disease - A comparison of prognostic models.

Authors:  Charles Meares; Alexander Badran; David Dewar
Journal:  J Bone Oncol       Date:  2019-02-13       Impact factor: 4.072

2.  Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis.

Authors:  Jiawen Zhao; Weijia Huang; Yongxian Wu; Yihuan Luo; Bo Wu; Jiwen Cheng; Junqiang Chen; Deyun Liu; Chengyang Li
Journal:  Cancer Cell Int       Date:  2020-01-10       Impact factor: 5.722

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.